Maxele Advisors, LLC Pfizer Inc Transaction History

Maxele Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Dec 01, 2025	SELL	$25.01 - $27.13 $192,927 - $209,280	-7,714 Closed	0 $0
Q4 2024 Dec 01, 2025	SELL	$24.8 - $30.19 $20,360 - $24,785	-821 Reduced 9.62%	7,714 $205 Million
Q3 2022 Dec 01, 2025	SELL	$43.76 - $53.42 $831 - $1,014	-19 Reduced 0.22%	8,535 $373 Million
Q4 2021 Dec 01, 2025	BUY	$41.32 - $61.25 $353,451 - $523,932	8,554 New	8,554 $505 Million

3,357

3.57B

86.1M

105M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $141B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Maxele Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Maxele Advisors, LLC with notifications on news.